PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,935 | -5.7% | 24,690 | +26.6% | 0.00% | -33.3% |
| Q2 2023 | $68,835 | -36.2% | 19,500 | -44.1% | 0.00% | -25.0% |
| Q1 2023 | $107,841 | -45.6% | 34,900 | -25.5% | 0.00% | -63.6% |
| Q4 2022 | $198,108 | +73.8% | 46,834 | +18.0% | 0.01% | +120.0% |
| Q1 2022 | $114,000 | -17.4% | 39,700 | -12.6% | 0.01% | -44.4% |
| Q4 2021 | $138,000 | -40.5% | 45,400 | +97.4% | 0.01% | -80.9% |
| Q3 2020 | $232,000 | – | 23,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |